TrovaGene Inc (TROV): A Sure Bet on a Human Papillomavirus (HPV) Test? – SmallCap Network

TrovaGene Inc (TROV): A Sure Bet on a Human Papillomavirus (HPV) Test?
SmallCap Network
Small cap TrovaGene Inc (NASDAQ: TROV) might not be a household name to many investors, but the company is worth taking a closer look at because it has developed a test for the Human Papillomavirus (HPV) – the most common sexually transmitted virus

and more »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *